Urokinase Excretion in Health and its Alteration in Certain Disease States

Summary

1. Urokinase excretion rates in normal subjects were found to be independent of age, sex and urine volume.

2. Urokinase excretion rates were found to be raised following the onset of myocardial infarction (p < 0.001) and after an attack of coronary insufficiency (p = 0.02). Excretion rates were depressed in patients suffering from carcinomatosis (p < 0.001), congestive cardiac failure (0.05 < p < 0.1) and uremia (p < 0.001).

3. These differences suggest that significant alterations in the plasma fibrinolytic system may result as a consequence of disease states.

• References

• 1 Sahli W. Über das Vorkommen von Pepsin und Trypsin im normalen menschlichen Harn. Pflügers Arch. ges. Physiol 1885; 36: 209
• 2 Williams J. R. B. The fibrinolytic activity of urine. Brit. J. exp. Path 1951; 32: 530
• 3 Astrup T, Sterndorff I. An activator of plasminogen in normal urine. Proc. Soc. exp. Biol. (N. Y.) 1952; 81: 675
• 4 Ploug J, Kjeldgaard N. O. Urokinase an activator of plasminogen from human urine, I. Isolation and properties. Biochim. biophys. Acta 1957; 24: 282
• 5 Alkjaersig N, Fletcher A. P, Sherry S. The activation of human plasminogen, II. A kinetic study of activation with trypsin, urokinase and streptokinase. J. biol. Chem 1958; 233: 91
• 6 Kjeldgaard N. O, Ploug J. Urokinase an activator of human plasminogen, II. Mechanism of plasminogen activation. Biochim. biophys. Acta 1957; 24: 289
• 7 Bjerrehuus I. Fibrinolytic activity of urine. Scand. J. clin. Lab. Invest 1952; 4: 179
• 8 v. Kaulla K, Swan H. Clotting deviation in man during cardiac by-pass: fibrinolysis and circulating anticoagulant. J. Thoracic Surg 1958; 36: 519
• 9 Sherry S, Fletcher A. P, Alkjaersig N. The fibrinolysin system: some physiological considerations.Symposium on Connective Tissue, Thrombosis and Atherosclerosis. Academic Press; New York: (In press, 1958)
• 10 Müllertz S. Fibrinolytic and fibrinogenolytic methods for estimating plasmin and trypsin. Acta physiol. scand 1954; 26: 174
• 11 v. Kaulla K. N. Methods for preparation of purified human thromboplastin and fibrinolysokinase from urine. Acta haemat. (Basel) 1956; 16: 315
• 12 Fletcher A. P, Alkjaersig N, Smyrniotis F, Sherry S. The Treatment of patients suffering from early myocardial infarction with massive and prolonged streptokinase therapy. Trans. Ass. Amer. Phys 1958; 71: 287
• 13 Fletcher A. P, Alkjaersig N, Sherry S. The clearance of heterologous protein from the circulation of normal and immunized man. J. clin. Invest 1958; 37: 1306
• 14 Sherry S, Fletcher A. P, Alkjaersig N, Smyrniotis F. E. An approach to intravascular fibrinolysis in man. Trans. Ass. Amer. Phys 1957; 70: 288
• 15 v. Kaulla K. N, Settles L. B. Relationship between human seminal fluid and the fibrinolytic system. Proc. Soc. exp. Biol. (N. Y.) 1953; 83: 692
• 16 Macfarlane R. G, Pilling J. Fibrinolytic activity of normal urine. Nature (Lond.) 1947; 159: 779
• 17 Bauer G. Diagnosis and management of peripheral venous disease. Amer. J. Med 1957; 23: 713
• 18 Allen E. V, Barker N. W, Hine E. A. In Peripheral Vascular Diseases. 2nd Ed. W. B. Saunders Co; Philadelphia: 1955
• 19 Heller B. I, Jacobson W. E. Renal hemodynamics in heart disease. Amer. Heart J 39: 188 1950;